Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High?

Shares of Immunome, Inc. (IMNM) have gained 19.1% over the past four weeks to close the last trading session at $9.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $24.50 indicates a potential upside of 158.2%.The mean estimate comprises eight short-term price targets with a standard deviation of $5.76. While the lowest estimate of $20 indicates an 110.8% increase from the cu ...